Ausgabe 1/2014
Inhalt (23 Artikel)
Tamoxifen-associated skin reactions in breast cancer patients: from case report to literature review
Peter Andrew, Sabira Valiani, Jennifer MacIsaac, Hamid Mithoowani, Shailendra Verma
Wild-type p53 inhibits pro-invasive properties of TGF-β3 in breast cancer, in part through regulation of EPHB2, a new TGF-β target gene
Suzanne Lam, Eliza Wiercinska, Amina F. A. S. Teunisse, Kirsten Lodder, Peter ten Dijke, Aart G. Jochemsen
Growth and metastatic behavior of molecularly well-characterized human breast cancer cell lines in mice
Muhammad Riaz, Buddy Setyono-Han, Mieke A. Timmermans, Anita M. Trapman, Joan Bolt-de Vries, Antoinette Hollestelle, Roel C. Janssens, Maxime P. Look, Mieke Schutte, John A. Foekens, John W. M. Martens
Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients
Mirjam E. Mast, Eline J. Vredeveld, Herman M. Credoe, Jaap van Egmond, Mark W. Heijenbrok, Eugen B. Hug, Patrick Kalk, Loes M. L. van Kempen-Harteveld, Erik W. Korevaar, Hans Paul van der Laan, Johannes A. Langendijk, Hans J. E. Rozema, Anna L. Petoukhova, Jacobus M. Schippers, Henk Struikmans, John H. Maduro
Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome
Katherine Drews-Elger, Elizabeth Iorns, Alexandra Dias, Philip Miller, Toby M. Ward, Sonja Dean, Jennifer Clarke, Adriana Campion-Flora, Daniel Nava Rodrigues, Jorge S. Reis-Filho, James M. Rae, Dafydd Thomas, Deborah Berry, Dorraya El-Ashry, Marc E. Lippman
Pigment epithelium-derived factor (PEDF) inhibits breast cancer metastasis by down-regulating fibronectin
Honghai Hong, Ti Zhou, Shuhuan Fang, Minghan Jia, Zumin Xu, Zhiyu Dai, Cen Li, Shuai Li, Lei Li, Ting Zhang, Weiwei Qi, Adham Sameer A. Bardeesi, Zhonghan Yang, Weibin Cai, Xia Yang, Guoquan Gao
Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series
Luigi Di Lauro, Patrizia Vici, Maddalena Barba, Laura Pizzuti, Domenico Sergi, Massimo Rinaldi, Anna Di Benedetto, Isabella Sperduti, Abeer M. Shaaban, Valerie Speirs, Marcella Mottolese, Ruggero De Maria, Marcello Maugeri-Saccà
Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial
Andrea DeCensi, Matteo Puntoni, Sara Gandini, Aliana Guerrieri-Gonzaga, Harriet Ann Johansson, Massimiliano Cazzaniga, Giancarlo Pruneri, Davide Serrano, Matthias Schwab, Ute Hofmann, Serena Mora, Valentina Aristarco, Debora Macis, Fabio Bassi, Alberto Luini, Matteo Lazzeroni, Bernardo Bonanni, Michael N. Pollak
Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients
So-Youn Jung, Kyung Hwan Shin, Myungsoo Kim, Seung Hyun Chung, Seeyoun Lee, Han-Sung Kang, Eun Sook Lee, Youngmee Kwon, Keun Seok Lee, In Hae Park, Jungsil Ro
A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007
Kathy D. Miller, Sandra K. Althouse, Lisle Nabell, Hope Rugo, Lisa Carey, Gretchen Kimmick, David R. Jones, Maria J. Merino, Patricia S. Steeg
A randomized, double-blind, active control, multicenter, dose-finding study of lipegfilgrastim (XM22) in breast cancer patients receiving myelosuppressive therapy
Anton Buchner, Reiner Elsässer, Peter Bias
Can mammographic and sonographic imaging features predict the Oncotype DX™ recurrence score in T1 and T2, hormone receptor positive, HER2 negative and axillary lymph node negative breast cancers?
Monica Maria Yepes, Ada Pat Romilly, Fernando Collado-Mesa, Jose Miguel Net, Richard Kiszonas, Kristopher L. Arheart, Daniel Young, Stefan Glück
Understanding process-of-care delays in surgical treatment of breast cancer at a comprehensive cancer center
Mehra Golshan, Katya Losk, Sarah Kadish, Nancy U. Lin, Judith Hirshfield-Bartek, Linda Cutone, Yasuaki Sagara, Fatih Aydogan, Kristen Camuso, Saul N. Weingart, Craig Bunnell
No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen
Tom Wei-Wu Chen, Ho-Min Chen, Ching-Hung Lin, Chiun-Sheng Huang, Ann-Lii Cheng, Mei-Shu Lai, Yen-Shen Lu
Pooled analysis of the prognostic relevance of progesterone receptor status in five German cohort studies
Jessica Salmen, Julia Neugebauer, Peter A. Fasching, Lothar Haeberle, Jens Huober, Achim Wöckel, Claudia Rauh, Florian Schuetz, Tobias Weissenbacher, Bernd Kost, Elmar Stickeler, Maximilian Klar, Marzenna Orlowska-Volk, Marisa Windfuhr-Blum, Joerg Heil, Joachim Rom, Christof Sohn, Tanja Fehm, Svjetlana Mohrmann, Christian R. Loehberg, Alexander Hein, Ruediger Schulz-Wendtland, Andreas D. Hartkopf, Sara Y. Brucker, Diethelm Wallwiener, Klaus Friese, Arndt Hartmann, Matthias W. Beckmann, Wolfgang Janni, Brigitte Rack
Diabetes, diabetes treatment and breast cancer prognosis
Juhua Luo, Beth Virnig, Michael Hendryx, Sijin Wen, Rowan Chelebowski, Chu Chen, Tomas Rohan, Lesley Tinker, Jean Wactawski-Wende, Lawrence Lessin, Karen Margolis
Racial disparities in risk of second breast tumors after ductal carcinoma in situ
Ying Liu, Graham A. Colditz, Sarah Gehlert, Melody Goodman
Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapy
Yinzhi Lai, Juan P. Palazzo, Massimo Cristofanilli, Terry Hyslop, Jesse Civan, Tiffany Avery, Ronald E. Myers, Bingshan Li, Zhong Ye, Jinliang Xing, Hushan Yang
Mammography interval and breast cancer mortality in women over the age of 75
Michael S. Simon, Sylvia Wassertheil-Smoller, Cynthia A. Thomson, Roberta M. Ray, F. Allan Hubbell, Lawrence Lessin, Dorothy S. Lane, Lew H. Kuller
Lapatinib-associated mucocutaneous toxicities are clinical predictors of improved progression-free survival in patients with human epidermal growth factor receptor (HER2)-positive advanced breast cancer
Kazuhiro Araki, Ippei Fukada, Rie Horii, Shunji Takahashi, Futoshi Akiyama, Takuji Iwase, Yoshinori Ito
Dual specificity phosphatase 4 gene expression in association with triple-negative breast cancer outcome
Michelle L. Baglia, Qiuyin Cai, Ying Zheng, Jie Wu, Yinghao Su, Fei Ye, Ping-Ping Bao, Hui Cai, Zhiguo Zhao, Justin Balko, Wei Zheng, Wei Lu, Xiao-Ou Shu
Expression of regulators of mitotic fidelity are associated with intercellular heterogeneity and chromosomal instability in primary breast cancer
Rebecca Roylance, David Endesfelder, Mariam Jamal-Hanjani, Rebecca A. Burrell, Patricia Gorman, Jil Sander, Niamh Murphy, Nicolai Juul Birkbak, Andrew M. Hanby, Valerie Speirs, Stephen R. D. Johnston, Maik Kschischo, Charles Swanton
Response to the article by Evangelista et al.: Use of a portable gamma camera for guiding surgical treatment in locally advanced breast cancer in a post-neoadjuvant therapy setting. Breast Cancer Res Treat 2014
Alexandre Bricou, Emmanuel Barranger